Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Current Assets (2018 - 2025)

TELA Bio (TELA) has 8 years of Current Assets data on record, last reported at $56.0 million in Q3 2025.

  • For Q3 2025, Current Assets rose 27.0% year-over-year to $56.0 million; the TTM value through Sep 2025 reached $56.0 million, up 27.0%, while the annual FY2024 figure was $78.1 million, 8.85% up from the prior year.
  • Current Assets reached $56.0 million in Q3 2025 per TELA's latest filing, down from $60.7 million in the prior quarter.
  • Across five years, Current Assets topped out at $89.2 million in Q2 2023 and bottomed at $44.1 million in Q3 2024.
  • Average Current Assets over 5 years is $64.3 million, with a median of $62.6 million recorded in 2024.
  • Peak YoY movement for Current Assets: soared 95.4% in 2023, then tumbled 46.35% in 2024.
  • A 5-year view of Current Assets shows it stood at $59.1 million in 2021, then increased by 5.74% to $62.4 million in 2022, then rose by 14.86% to $71.7 million in 2023, then grew by 8.85% to $78.1 million in 2024, then decreased by 28.21% to $56.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $56.0 million in Q3 2025, $60.7 million in Q2 2025, and $69.7 million in Q1 2025.